Predictive value of topoisomerase IIα and other prognostic factors for epirubicin chemotherapy in advanced breast cancer

British Journal of Cancer

Volumn 77, Issue 12, 1998, Pages 2267-2273

  Jarvinen, T A H ^a   Holli, K ^a   Kuukasjarvi, T ^a   Isola, J J ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Breast cancer; c erbB2 oncogene; Chemotherapy; DNA flow cytometry; Hormone receptor; Topoisomerase II

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); EPIRUBICIN; ESTROGEN RECEPTOR; ONCOPROTEIN; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE C ERB; PLOIDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS;

EID: 0031775808     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.377     Document Type: Article

References (57)